Vichi P J, Tritton T R
Vermont Cancer Center, Burlington.
Cancer Res. 1993 Nov 1;53(21):5237-43.
We present studies which suggest that the cytotoxic action of Adriamycin (ADR) may involve intracellular pathways of vesicular transport. The movement of proteins or lipids from the endoplasmic reticulum to the plasma membrane via the Golgi organelle and associated compartments exhibits several temperature-sensitive steps between 15 degrees C and 20 degrees C. In this same temperature range, ADR loses its cytotoxic capacity. Using the inhibitor brefeldin A (BFA), we have investigated the possible role of intravesicular trafficking in the loss of ADR activity and the induction of protection from cytotoxicity at low temperature in L1210 cells. We show here that cells pretreated at 37 degrees C for 2 h with BFA could be protected from a subsequent exposure to ADR. The concentration causing 50% inhibition, determined by cloning in soft agar, was increased approximately 3.5 fold. L1210 cells could also be protected from the topoisomerase II inhibitors etoposide and amsacrine, but to a lesser extent; the concentration causing 50% inhibition for the latter inhibitors were increased 2-fold. Spectrofluorometric analysis of intracellular ADR accumulation revealed that there was no significant difference in the level of ADR in cells with or without BFA pretreatment. In addition, examination of ADR-induced cleavable complex formation by alkaline elution showed no significant difference in the level of DNA strand breaks in cells which had been pretreated with BFA even though there was a large difference in survival. Further examination of the persistence of DNA damage after a period of up to 6 h of repair revealed that cells which were pretreated with BFA removed DNA strand breaks at rates equivalent to those of cells which had received ADR directly. These results suggest that the protective effect induced by brefeldin A does not involve uptake, DNA damage, or repair but instead implicates protein or lipid interactions which may be independent of DNA damage and which may influence critical events that take place after the topoisomerase II-DNA complex has been formed.
我们展示的研究表明,阿霉素(ADR)的细胞毒性作用可能涉及囊泡运输的细胞内途径。蛋白质或脂质从内质网经高尔基体及其相关区室转运至质膜的过程在15摄氏度至20摄氏度之间呈现出几个对温度敏感的步骤。在相同温度范围内,ADR失去其细胞毒性能力。我们使用抑制剂布雷菲德菌素A(BFA),研究了囊泡内运输在ADR活性丧失以及L1210细胞在低温下免受细胞毒性诱导的保护作用中可能发挥的作用。我们在此表明,在37摄氏度下用BFA预处理2小时的细胞可免受随后ADR暴露的影响。通过软琼脂克隆测定的导致50%抑制的浓度增加了约3.5倍。L1210细胞也可免受拓扑异构酶II抑制剂依托泊苷和安吖啶的影响,但程度较小;导致后一种抑制剂50%抑制的浓度增加了2倍。对细胞内ADR积累的荧光光谱分析表明,有无BFA预处理的细胞中ADR水平没有显著差异。此外,通过碱性洗脱检测ADR诱导的可裂解复合物形成表明,即使存活率存在很大差异,用BFA预处理的细胞中DNA链断裂水平也没有显著差异。对长达6小时修复期后DNA损伤持续性的进一步检测表明,用BFA预处理的细胞去除DNA链断裂的速率与直接接受ADR的细胞相当。这些结果表明,布雷菲德菌素A诱导的保护作用不涉及摄取、DNA损伤或修复,而是涉及蛋白质或脂质相互作用,这些相互作用可能独立于DNA损伤,并且可能影响拓扑异构酶II - DNA复合物形成后发生的关键事件。